The Company submitted an sNDA for ZORYVE foam for scalp and body psoriasis to the FDA based on the positive results from the pivotal ARRECTOR Phase 3 trial and a Phase 2b trial, which was accepted by ...
Thirty per cent of those who have stopped looking say they aren’t doing so because there is none available in their area.
These projects are developed by small and large-scale architecture offices from around the world and submitted openly to the ...
CTV News Channel is Canada's 24-hour all-news network. Watch the latest headlines from Canada and around the world.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback